Title:
TREATMENT OF PSORIASIS
Document Type and Number:
WIPO Patent Application WO2001066101
Kind Code:
A3
Abstract:
Norepinephrine reuptake inhibitors are used to treat psoriasis.
Inventors:
THOMASSON HOLLY READ (US)
Application Number:
PCT/US2001/005260
Publication Date:
February 07, 2002
Filing Date:
February 20, 2001
Export Citation:
Assignee:
LILLY CO ELI (US)
THOMASSON HOLLY READ (US)
THOMASSON HOLLY READ (US)
International Classes:
A61K31/00; A61K31/137; A61K45/00; A61K31/138; A61K31/145; A61K31/16; A61K31/381; A61K31/5375; A61P17/06; (IPC1-7): A61K31/135; A61P17/06
Other References:
ALPSOY E. ET AL.: "Is the efficacy of topical corticosteroid therapy for psoriasis vaulgaris enhanced by concurrent moclobemide therapy? A double-blind, placebo-controlled study.", J. AM. ACAD. DERMATOL., vol. 38, no. 2, 1998, pages 197 - 200, XP001018338
STIEFELHAGEN P.: "[Progress and education in medicine. Part II: Depressive disorders, possibilities for prenatal therapy, autoimmune diseases and drug therapy]. FORTSCHRITT UND FORTBILDUNG IN DER MEDIZIN: TEIL II: DEPRESSIVE ERKRANKUNGEN, PRANATALE THERAPIEMOGLICHKEITEN, AUTOIMMUNERKRANKUNGEN, ARZNEIMITTELTHERAPIE.", INTERNIST, (1999) 40/6 (686-691)., XP001018070
HOPKINS S.: "A year of therapeutic advances.", MANUFACTURING CHEMIST, (1998) 69/4 (16-17,21)., XP001002924
RILEY T.N. ET AL: "Major drugs highlight '94.", U.S. PHARMACIST, (1994) 19/10 (55-63+67-82+86-87+91-104)., XP001021560
STIEFELHAGEN P.: "[Progress and education in medicine. Part II: Depressive disorders, possibilities for prenatal therapy, autoimmune diseases and drug therapy]. FORTSCHRITT UND FORTBILDUNG IN DER MEDIZIN: TEIL II: DEPRESSIVE ERKRANKUNGEN, PRANATALE THERAPIEMOGLICHKEITEN, AUTOIMMUNERKRANKUNGEN, ARZNEIMITTELTHERAPIE.", INTERNIST, (1999) 40/6 (686-691)., XP001018070
HOPKINS S.: "A year of therapeutic advances.", MANUFACTURING CHEMIST, (1998) 69/4 (16-17,21)., XP001002924
RILEY T.N. ET AL: "Major drugs highlight '94.", U.S. PHARMACIST, (1994) 19/10 (55-63+67-82+86-87+91-104)., XP001021560
Download PDF: